CNS PHARMACEUTICALS, INC. (CNSP) Social Stream



CNS PHARMACEUTICALS, INC. (CNSP): $0.25

0.01 (+2.08%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CNS Pharmaceuticals Inc (CNSP) Price Targets From Analysts

Use the tables below to see what analysts covering CNS Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-03 3 $10 $4 $7.333 $0.34 2056.76%
2021-12-08 2 $10 $4 $7 $0.34 1958.82%

The Trend in the Analyst Price Target


CNSP's average price target has moved down $1.33 over the prior 125 days.

Over the past 36 weeks, CNSP's average upside potential has been 360.93%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-03 0 10 7 8.33 2.36 252.97%
2021-04-25 0 10 7 8.33 2.05 306.34%
2021-05-22 0 10 7 8.33 1.87 345.45%
2021-08-14 3 10 7 8.33 1.67 398.8%
2021-09-11 3 10 4 6.25 1.53 308.5%

CNSP Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


CNSP's average broker recommendation rating improved by 1 over the prior 61 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • CNS Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is greater than 299.63% of all US stocks.
  • CNSP has a higher average analyst price target than 16.07% of all US stocks.
  • To contextualize these metrics, consider that out of Healthcare stocks, CNS Pharmaceuticals Inc's number of analysts covering the stock is higher than 29.87% of them.
  • To contextualize these metrics, consider that out of stocks in the micro market cap category, CNS Pharmaceuticals Inc's variance in analysts' estimates is lower than -154.78% of them.

In the Pharmaceutical Products industry, CLSN, CLRB, and CFRX are the three stocks most similar to CNS Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.

Is CNSP a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4887 seconds.